Nov 10, 2021 / 06:50PM GMT
Albert J. William Rice - Crédit Suisse AG - Research Division - Research Analyst
Hi, everyone. I'm A.J. Rice, the health care service analyst at Credit Suisse. We're very pleased to have up next presenting at the conference, MEDNAX. We're joined today by Mark Ordan, the CEO of MEDNAX. We've got Dr. Jim Swift, Chief Development Officer; and Charlie Lynch, who heads up Investor Relations for MEDNAX. We appreciate you guys participating, once again, in our conference this year.
Questions and Answers:
Albert J. William Rice - Crédit Suisse AG - Research Division - Research AnalystAnd I guess just to start off, we're off the heels of the third quarter release. And in the context of that release, you guys anticipate -- updated your outlook for this year, $250 million of EBITDA. Say that you expect to exceed $270 million next year. When you think about that puts and takes, especially for next year, what are the open questions, if there are open questions that would finalize that guidance, where are the
Trustpilot
